This invention relates to new quinolone based compounds that exhibit prolyl hydroxylase inhibitory activity. This invention also relates to methods of increasing HIF levels or activity in a subject or treating a condition associated with HIF levels or activity in a subject by administering to the subject at least one quinolone based compound. This invention further involves assays for the detection of a hydroxyproline residue in a HIF molecule.

 
Web www.patentalert.com

< Antibodies to SARS coronavirus

< DKR polypeptides

> Methods for treating diabetes using fibroblast growth factor-like polypeptides

> Stable polypeptide formulations

~ 00612